Cordlife raises stake in Malaysia-listed firm StemLife to 31.81 per cent
Singapore-listed Cordlife Group announced on Monday that it has acquired a further 11.89 per cent stake in StemLife, an associated company of Cordlife. This brings Cordlife's total stake to about 31.81 per cent in StemLife.
Cordlife, a provider of cord blood and tissue banking services said in a statement that a cash payment of RM17.66 million was made for the stake in Malaysia-listed StemLife.
StemLife provides cord-blood banking services.
Cordlife also aspires to be a multi-product healthcare company, with a focus on the mother and child segment.